Volume 23, Issue 8, Pages (May 2018)

Slides:



Advertisements
Similar presentations
Volume 39, Issue 3, Pages (September 2013)
Advertisements

Volume 19, Issue 1, Pages (July 2003)
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
Volume 18, Issue 5, Pages (May 2003)
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
Surrogate-Light-Chain Silencing Is Not Critical for the Limitation of Pre-B Cell Expansion but Is for the Termination of Constitutive Signaling  Pieter.
Volume 40, Issue 2, Pages (February 2014)
Development and Migration of Plasma Cells in the Mouse Lymph Node
Volume 11, Issue 12, Pages (June 2015)
Volume 18, Issue 1, Pages (January 2017)
Volume 42, Issue 5, Pages (May 2015)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 11, Issue 5, Pages (November 1999)
The Role of Dendritic Cells in S
Volume 38, Issue 3, Pages (March 2013)
Interleukin-3Rα+ Myeloid Dendritic Cells and Mast Cells Develop Simultaneously from Different Bone Marrow Precursors in Cultures with Interleukin-3  Thomas.
Volume 40, Issue 5, Pages (May 2014)
Balthazar B Cazac, Jürgen Roes  Immunity 
Positive Selection from Newly Formed to Marginal Zone B Cells Depends on the Rate of Clonal Production, CD19, and btk  Flavius Martin, John F. Kearney 
Volume 43, Issue 4, Pages (October 2015)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 24, Issue 3, Pages (March 2006)
Volume 26, Issue 5, Pages (May 2007)
Volume 21, Issue 3, Pages (September 2004)
CD22 is a negative regulator of B-cell receptor signalling
Volume 15, Issue 9, Pages (May 2016)
Volume 34, Issue 5, Pages (May 2011)
Volume 28, Issue 3, Pages (March 2008)
Volume 45, Issue 1, Pages (July 2016)
Volume 22, Issue 4, Pages (January 2018)
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 19, Issue 3, Pages (April 2017)
The Physiologic Role of CD19 Cytoplasmic Tyrosines
Karin E. de Visser, Lidiya V. Korets, Lisa M. Coussens  Cancer Cell 
Volume 13, Issue 12, Pages (December 2015)
Volume 29, Issue 2, Pages (August 2008)
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 14, Issue 5, Pages (May 2001)
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells  Wei Luo, Florian.
Volume 17, Issue 1, Pages (September 2016)
Volume 29, Issue 1, Pages (July 2008)
Fluorescent In Vivo Detection Reveals that IgE+ B Cells Are Restrained by an Intrinsic Cell Fate Predisposition  Zhiyong Yang, Brandon M. Sullivan, Christopher D.C.
Volume 13, Issue 6, Pages (November 2015)
Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens  Flavius Martin, Alyce M Oliver, John.
Volume 37, Issue 5, Pages (November 2012)
Volume 48, Issue 2, Pages e6 (February 2018)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 19, Issue 3, Pages (April 2017)
Self-Restrained B Cells Arise following Membrane IgE Expression
Negative Selection of Immature B Cells by Receptor Editing or Deletion Is Determined by Site of Antigen Encounter  Peter C Sandel, John G Monroe  Immunity 
Volume 19, Issue 4, Pages (October 2003)
Volume 31, Issue 4, Pages (October 2009)
Volume 25, Issue 1, Pages (July 2006)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Volume 37, Issue 5, Pages (November 2012)
Volume 21, Issue 1, Pages (October 2017)
Volume 42, Issue 4, Pages (April 2015)
Volume 12, Issue 2, Pages (July 2015)
Identification of Anergic B Cells within a Wild-Type Repertoire
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 23, Issue 3, Pages (September 2005)
Volume 17, Issue 3, Pages (September 2002)
Volume 87, Issue 2, Pages (October 1996)
Volume 16, Issue 3, Pages (March 2002)
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
Volume 21, Issue 1, Pages (October 2017)
Volume 30, Issue 5, Pages (May 2009)
Volume 30, Issue 2, Pages (February 2009)
Volume 39, Issue 5, Pages (November 2013)
Volume 25, Issue 4, Pages (October 2006)
Presentation transcript:

Volume 23, Issue 8, Pages 2342-2353 (May 2018) Myosin IIa Promotes Antibody Responses by Regulating B Cell Activation, Acquisition of Antigen, and Proliferation  Robbert Hoogeboom, Elizabeth M. Natkanski, Carla R. Nowosad, Dessislava Malinova, Rajesh P. Menon, Antonio Casal, Pavel Tolar  Cell Reports  Volume 23, Issue 8, Pages 2342-2353 (May 2018) DOI: 10.1016/j.celrep.2018.04.087 Copyright © 2018 The Author(s) Terms and Conditions

Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 1 Disturbed B Cell Development and Maintenance after B Cell-Specific Deletion of Myosin IIa (A) Flow cytometric analysis of B220+CD19+ cells in the bone marrow (BM) of Mb1Cre+Myh9wt/fl and Mb1Cre+Myh9fl/fl mice. (B) Quantification of precursor B cell subsets in the BM of Mb1Cre+Myh9wt/wt (n = 3), Mb1Cre+Myh9wt/fl (n = 4), Mb1Cre+Myh9fl/fl (n = 4), and Cre-negative littermates (n = 4). (C) Flow cytometric analysis of B220+AA4.1− cells in spleens of Mb1Cre+Myh9wt/fl and Mb1Cre+Myh9fl/fl mice. (D) Quantification of B cell subsets in spleens of Mb1Cre+Myh9wt/wt (n = 3), Mb1Cre+Myh9wt/fl (n = 4), Mb1Cre+Myh9fl/fl (n = 4), and Cre-negative littermates (n = 4). (E) Flow cytometric analysis of B220+AA4.1− cells in spleens of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl mice. (F) Quantification of B cell subsets in spleens of CD23Cre+Myh9wt/fl (n = 6) and CD23Cre+Myh9fl/fl (n = 4) mice. (G) Flow cytometric analysis of B220+ cells in the peritoneal cavity of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl mice. (H) Quantification of B cell subsets in the peritoneal cavity of CD23Cre+Myh9wt/fl (n = 6) and CD23Cre+Myh9fl/fl (n = 4) mice. (I) Quantification of B cell subsets 14 days after the start of tamoxifen treatment in spleens of R26ERT2Cre+Myh9wt/wt, R26ERT2Cre+Myh9wt/fl, R26ERT2Cre+Myh9fl/fl, and Cre-negative mixed BM chimeras (n = 5). (J) Quantification of MZ B cell numbers in spleens of R26ERT2Cre+Myh9wt/fl and R26ERT2Cre+Myh9fl/fl mice over time since the start of tamoxifen treatment. Plotted are means ± SD per mouse. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (unpaired t test). Trans, transitional B cells; MZ, marginal zone B cells; Fo, follicular B cells; GC, B220+Fas+CD38− germinal center B cells. See also Figures S1 and S2. Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 2 Myosin IIa-Deficient Follicular B Cells Express Altered Levels of Surface Activation Markers (A) Surface expression of CD23, IgM, and MHC class II on follicular B cells of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl mice. (B) Relative expression of surface CD23, IgM, and MHC class II on follicular B cells of R26ERT2Cre+Myh9wt/fl and R26ERT2Cre+Myh9fl/fl mice 18 days after the start of tamoxifen treatment. Each dot represents one mouse. Horizontal bars reflect mean ± SD. Data are normalized on expression levels of Cre+Myh9wt/fl littermate follicular B cells. ∗∗p < 0.01, ∗∗∗p < 0.001 (unpaired t test). See also Figure S3. Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 3 Myosin IIa-Deficient B Cells Are Less Efficient at Internalizing Membrane-Bound Antigen In Vitro (A) Side view reconstructions and quantification of internalized antigen of follicular B cells (blue) from CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl mice after 40 min of interaction with plasma membrane sheet (PMS)-bound antigen (red). (B) Top view of synapse plane showing pBlnk staining (green) in follicular B cells (blue) from CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl mice after 15 min of interaction with PMS-bound antigen (red). (C) Quantification of synaptic pBlnk (left), pSyk (middle), and pErk (right) after 20, 20, and 15 min of interaction with PMS, respectively. Cells that landed outside of PMS were used as unstimulated controls. Mean ± SEM (n > 192 cells). ∗∗∗p < 0.001 (Mann-Whitney U test). Fu, fluorescence units. See also Figure S5. Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 4 Disturbed Migration and In Vivo Trafficking of Myosin IIa-Deficient B Cells (A) Velocity of CXCL13-activated CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl B cells on an ICAM-1-coated glass surface (n > 48 cells). ∗∗∗p < 0.001 (Mann-Whitney U test). (B) Directional migration through BSA, ICAM-1, and anti-Igκ-coated Transwells of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl B cells toward the indicated chemokines. Data are normalized on Cxcl12-mediated migration of CD23Cre+Myh9wt/fl B cells. Mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (unpaired t test). (C) Ratio of B cells from CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl mice after i.v. injection into C57BL/6J mice normalized to input ratio (n = 8 mice). Mean ± SD. LN, lymph node. See also Figure S6. Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 5 Myosin IIa Is Required for Efficient Acquisition of Low-Affinity Antigen In Vivo (A) Flow cytometric analysis and quantification of HEL-streptavidin-PE complex capture by B220+ cells from CD23Cre+Myh9fl/wtSWHEL or CD23Cre+Myh9fl/flSWHEL mice 14 hr after transfer into HEL-streptavidin-PE-immunized CD45.1 mice. Plotted is the MFI of PE+ cells, paired per mouse. (B) Flow cytometric analysis and quantification of HEL3x-streptavidin-PE complex capture by B220+ cells from CD23Cre+Myh9fl/wtSWHEL or CD23Cre+Myh9fl/flSWHEL mice 14 hr after transfer into HEL3x-streptavidin-PE-immunized CD45.1 mice. Plotted is the MFI of PE+ cells, paired per mouse. Flow cytometry plots display data of a representative experiment. ∗p < 0.05, ∗∗p < 0.01 (paired t test). See also Figure S7. Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 6 Myosin IIa-Deficient B Cells Have a Defect in Cytokinesis (A) Percentage of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl B cells that have divided after 48 hr of cell culture in the presence of indicated stimuli. (B) Light microscopy images of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl B cells stimulated with CpG for 48 hr. (C) Size of BM B220+CD19+CD2−IgM− pro-B cells of Mb1Cre+Myh9wt/fl and Mb1Cre+Myh9fl/fl mice. (D) Flow cytometric analysis of propidium iodide incorporation of CD23Cre+Myh9wt/fl and CD23Cre+Myh9fl/fl B cells stimulated with CpG for 48 hr. (E) Quantification of cells in G2/M phase and cells with more than 4N of DNA after 48 hr of CpG stimulation. Means ± SD. ∗∗p < 0.01, ∗∗∗p < 0.001 (unpaired t test). Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions

Figure 7 Myosin IIa Is Essential for Antibody Responses (A) Serum immunoglobulin levels of CD23Cre+Myh9fl/wt and CD23Cre+Myh9fl/fl mice. (B) NP-specific immunoglobulin levels of CD23Cre+Myh9fl/wt and CD23Cre+Myh9fl/fl BM-reconstituted mice after immunization with the T-dependent antigen NP-CGG (n = 10). (C) NP-specific immunoglobulin levels of CD23Cre+Myh9fl/wt and CD23Cre+Myh9fl/fl BM-reconstituted mice after immunization with the T-independent antigen NP-Ficoll (n = 5). Dots represent individual mice analyzed in two experiments. Horizontal bars reflect mean ± SD. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (unpaired t test). Cell Reports 2018 23, 2342-2353DOI: (10.1016/j.celrep.2018.04.087) Copyright © 2018 The Author(s) Terms and Conditions